259 related articles for article (PubMed ID: 26937135)
1. Estrogen receptors in gastric cancer: Advances and perspectives.
Ur Rahman MS; Cao J
World J Gastroenterol; 2016 Feb; 22(8):2475-82. PubMed ID: 26937135
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathologic significance of estrogen receptors in human gastric carcinoma.
Wesołowska M; Pawlik P; Jagodziński PP
Biomed Pharmacother; 2016 Oct; 83():314-322. PubMed ID: 27399808
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic targets for the primary gallbladder carcinoma: estrogen receptors.
Zhang LQ; Zhang XD; Xu J; Wan Y; Qu K; Zhang JY; Wang ZX; Wei JC; Meng FD; Tai MH; Zhou L; Liu C
Asian Pac J Cancer Prev; 2013; 14(4):2185-90. PubMed ID: 23725110
[TBL] [Abstract][Full Text] [Related]
4. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
[TBL] [Abstract][Full Text] [Related]
5. Estrogen signaling: a subtle balance between ER alpha and ER beta.
Matthews J; Gustafsson JA
Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
7. Reliability of estrogen receptors in predicting response to antiestrogens.
Valavaara R
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):14-8. PubMed ID: 9165501
[TBL] [Abstract][Full Text] [Related]
8. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma and estrogen receptors: Polymorphisms and isoforms relations and implications.
Baldissera VD; Alves AF; Almeida S; Porawski M; Giovenardi M
Med Hypotheses; 2016 Jan; 86():67-70. PubMed ID: 26804600
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between ERs and signal transducer and activator of transcription 5 is E2 dependent and involves two functionally separate mechanisms.
Faulds MH; Pettersson K; Gustafsson JA; Haldosén LA
Mol Endocrinol; 2001 Nov; 15(11):1929-40. PubMed ID: 11682624
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of tamoxifen resistance.
Ring A; Dowsett M
Endocr Relat Cancer; 2004 Dec; 11(4):643-58. PubMed ID: 15613444
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of estrogen receptor rapid responses to xenoestrogens: Physiological outcomes.
Marino M; Pellegrini M; La Rosa P; Acconcia F
Steroids; 2012 Aug; 77(10):910-7. PubMed ID: 22410438
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptors: how do they signal and what are their targets.
Heldring N; Pike A; Andersson S; Matthews J; Cheng G; Hartman J; Tujague M; Ström A; Treuter E; Warner M; Gustafsson JA
Physiol Rev; 2007 Jul; 87(3):905-31. PubMed ID: 17615392
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors: therapies targeted to receptor subtypes.
Nilsson S; Gustafsson JÅ
Clin Pharmacol Ther; 2011 Jan; 89(1):44-55. PubMed ID: 21124311
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
19. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
Chen DH; Yu JW; Jiang BJ
World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
[TBL] [Abstract][Full Text] [Related]
20. Sex hormone receptors in breast cancer.
D'Abreo N; Hindenburg AA
Vitam Horm; 2013; 93():99-133. PubMed ID: 23810004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
